We are live on ! Find out more
AMRX icon

Amneal Pharmaceuticals
AMRX

140 hedge funds and large institutions have $394M invested in Amneal Pharmaceuticals in 2020 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 39 increasing their positions, 49 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

129% more call options, than puts

Call options by funds: $1.33M | Put options by funds: $581K

13% more first-time investments, than exits

New positions opened: 18 | Existing positions closed: 16

1% more funds holding

Funds holding: 139 → 140 (+1)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0.24% less ownership

Funds ownership: 69.03% → 68.79% (-0.24%)

19% less capital invested

Capital invested by funds: $484M → $394M (-$90.5M)

20% less repeat investments, than reductions

Existing positions increased: 39 | Existing positions reduced: 49

Holders
140
Holders Change
+1
Holders Change %
+0.72%
% of All Funds
2.82%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
18
Increased
39
Reduced
49
Closed
16
Calls
$1.33M
Puts
$581K
Net Calls
+$751K
Net Calls Change
+$42K

Top Buyers

Rank Fund Capital Flow
1
EP
Eversept Partners
New York
+$7.57M
2
Citadel Advisors
Citadel Advisors
Florida
+$3.07M
3
PM
Prosight Management
Texas
+$2.19M
4
MSL
Mackay Shields LLC
New York
+$997K
5
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
+$985K

Top Sellers

Rank Fund Capital Flow
1
Arrowstreet Capital
Arrowstreet Capital
Massachusetts
-$5.02M
2
SGH
Sivik Global Healthcare
Connecticut
-$2.86M
3
Assenagon Asset Management
Assenagon Asset Management
Luxembourg
-$2.68M
4
Vanguard Group
Vanguard Group
Pennsylvania
-$2M
5
BlackRock
BlackRock
New York
-$1.54M
Name Holding Trade Value Shares
Change 		Change in
Stake
TFA
126
Toth Financial Advisory
Virginia
$4K – – –
ASN
127
Advisory Services Network
Georgia
$4K +$4.43K +1,037 New
US Bancorp
128
US Bancorp
Minnesota
$3K -$6.42K -1,500 -65%
BWA
129
Burt Wealth Advisors
Maryland
$2K – – –
LC
130
Lindbrook Capital
California
$2K – – –
TF
131
TimeScale Financial
Massachusetts
$2K – – –
VNA
132
Valley National Advisers
Pennsylvania
$2K – – –
S
133
SignatureFD
Georgia
$1K – – –
Millennium Management
134
Millennium Management
New York
$272 -$207K -48,504 -41%
SGH
135
Sivik Global Healthcare
Connecticut
– -$2.86M -600,000 Closed
First Trust Advisors
136
First Trust Advisors
Illinois
– -$1.05M -221,535 Closed
QC
137
Quadrature Capital
United Kingdom
– -$420K -88,300 Closed
SFM
138
Systematic Financial Management
New Jersey
– -$302K -63,395 Closed
SG Americas Securities
139
SG Americas Securities
New York
– -$276K -57,907 Closed
SIM
140
Spark Investment Management
New York
– -$143K -30,100 Closed
CMBA
141
C.M. Bidwell & Associates
Hawaii
– -$141K -29,550 Closed
BFM
142
Boothbay Fund Management
New York
– -$137K -28,875 Closed
AIM
143
Alambic Investment Management
California
– -$93K -19,493 Closed
HSBC Holdings
144
HSBC Holdings
United Kingdom
– -$89K -18,751 Closed
SAM
145
Sectoral Asset Management
Quebec, Canada
– -$84K -17,700 Closed
PTP
146
Platform Technology Partners
New York
– -$63K -13,250 Closed
Lazard Asset Management
147
Lazard Asset Management
New York
– -$56K -11,839 Closed
PAG
148
Private Advisor Group
New Jersey
– -$10K -2,012 Closed
IA
149
IFP Advisors
Florida
– -$8.55K -2,000 Closed
CAPTRUST Financial Advisors
150
CAPTRUST Financial Advisors
North Carolina
– -$1.07K -250 -83%
2 3 4 5
6

AMRX Hedge Fund Activity: Q3 2020 in Review

140 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Amneal Pharmaceuticals (AMRX) for Q3 2020, worth a combined $394M — down 19% from $484M a quarter earlier.

Buyers outnumbered sellers: 18 funds opened new AMRX positions and 16 closed out — a net gain of 2 holders — while 39 added to existing stakes and 49 trimmed.

The largest buyer was Eversept Partners, adding an estimated $7.57M. The largest seller was Arrowstreet Capital, cutting an estimated $5.02M.

  • 140 institutional investors held Amneal Pharmaceuticals (AMRX) as of Q3 2020, up from 139 in Q2 2020.
  • Funds reported $394M of Amneal Pharmaceuticals stock for Q3 2020, down 19% quarter-over-quarter.
  • 18 funds opened new Amneal Pharmaceuticals positions in Q3 2020 and 16 closed out, a net change of +2 holders.
  • The largest Amneal Pharmaceuticals buyer in Q3 2020 was Eversept Partners, an estimated $7.57M added.
  • The largest Amneal Pharmaceuticals seller in Q3 2020 was Arrowstreet Capital, an estimated $5.02M sold.

Based on aggregated 13F filings for Q3 2020.